EVALUATION OF PSORIASIS TREATMENT WITH ESOMEPRAZOLE - A PILOT STUDY

by Mauro BAFUTTO, Enio Chaves OLIVEIRA, Schlioma ZATERKA

Evaluation of small intestine bacterial overgrowth in patients with functional dyspepsia through H2 breath test

by Michelle Bafutto Gomes Costa, Itaciron Luz Azeredo Jr., Ricardo Duarte Marciano, Luciana Morelli Caldeira, Mauro Bafutto
Published 2012-12-01

Evaluation of small intestine bacterial overgrowth in patients with functional dyspepsia through H2 breath test Avaliação de supercrescimento bacteriano no intestino delgado em pac...

by Michelle Bafutto Gomes Costa, Itaciron Luz Azeredo Jr., Ricardo Duarte Marciano, Luciana Morelli Caldeira, Mauro Bafutto
Published 2012-12-01

Treatment of postinfectious irritable bowel syndrome and noninfective irritable bowel syndrome with mesalazine

by Mauro Bafutto, José Roberto de Almeida, Nayle Vilela Leite, Enio Chaves Oliveira, Salustiano Gabriel-Neto, Joffre Rezende-Filho
Published 2011-03-01

TREATMENT OF DIARRHEA-PREDOMINANT IRRITABLE BOWEL SYNDROME WITH MESALAZINE AND/OR SACCHAROMYCES BOULARDII

by Mauro BAFUTTO, Jose Roberto de ALMEIDA, Nayle Vilela LEITE, Michelle Bafutto Gomes COSTA, Enio Chaves de OLIVEIRA, Joffre RESENDE-FILHO
Published 2013-12-01

ORAL ADMINISTRATION OF EXOGENOUS LACTASE IN TABLETS FOR PATIENTS DIAGNOSED WITH LACTOSE INTOLERANCE DUE TO PRIMARY HYPOLACTASIA

by Carlos Fernando de Magalhães FRANCESCONI, Marta Brenner MACHADO, Flavio STEINWURZ, Rodrigo Bremer NONES, Flávio Antonio QUILICI, Wilson Roberto CATAPANI, Sender Jankiel MISZPUTEN, Mauro BAFUTTO

A randomized controlled trial of the efficacy and safety of CCX282-B, an orally-administered blocker of chemokine receptor CCR9, for patients with Crohn's disease.

by Satish Keshav, Tomáš Vaňásek, Yaron Niv, Robert Petryka, Stephanie Howaldt, Mauro Bafutto, István Rácz, David Hetzel, Ole Haagen Nielsen, Séverine Vermeire, Walter Reinisch, Per Karlén, Stefan Schreiber, Thomas J Schall, Pirow Bekker, Prospective Randomized Oral-Therapy Evaluation in Crohn’s Disease Trial-1 PROTECT-1 Study Group
Published 2013-01-01